# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-003448
Filing Date
2021-11-08
Accepted
2021-11-08 16:04:00
Documents
64
Period of Report
2021-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | elym-20210930.htm iXBRL | 10-Q | 2942007
2 | EX-3.2 | elym-ex3_2.htm | EX-3.2 | 271241
3 | EX-31.1 | elym-ex31_1.htm | EX-31.1 | 18159
4 | EX-31.2 | elym-ex31_2.htm | EX-31.2 | 18242
5 | EX-32.1 | elym-ex32_1.htm | EX-32.1 | 11524
6 | EX-32.2 | elym-ex32_2.htm | EX-32.2 | 11622
7 | GRAPHIC | img155835445_0.jpg | GRAPHIC | 1267406
| Complete submission text file | 0000950170-21-003448.txt |  | 11562842

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | elym-20210930_pre.xml | EX-101.PRE | 273955
9 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | elym-20210930_lab.xml | EX-101.LAB | 366131
10 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | elym-20210930_cal.xml | EX-101.CAL | 32129
11 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | elym-20210930_def.xml | EX-101.DEF | 133243
12 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | elym-20210930.xsd | EX-101.SCH | 44738
13 | EXTRACTED XBRL INSTANCE DOCUMENT | elym-20210930_htm.xml | XML | 1488098

Mailing Address 23515 NE NOVELTY HILL ROAD SUITE B221 #125 REDMOND WA 98053
Business Address 23515 NE NOVELTY HILL ROAD SUITE B221 #125 REDMOND WA 98053 425-276-2300
Eliem Therapeutics, Inc. (Filer) CIK: 0001768446 (see all company filings)

EIN.: 832273741 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40708 | Film No.: 211387868
SIC: 2834 Pharmaceutical Preparations